FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical ...
Sanara MedTech announced the discontinuation of its Tissue Health Plus (THP) division and reported third-quarter earnings, with sales reaching US$26.33 million and a net loss of US$30.41 million for ...
Hosted on MSN
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus
Seth Yon, President and CEO, opened with, "As the recently appointed President and CEO, I'll begin with a brief introduction and provide some opening thoughts on Sanara MedTech." Yon emphasized his ...
Taylor indicated, "Our team remains focused this year on delivering net revenue growth, driven by our Sanara Surgical segment. We continue to expect improvements in our Sanara Surgical segment ...
FORT WORTH, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq ...
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (SMTI), a medical ...
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results